Warning Letter Roundup & Recap – August 2022
The US FDA handed warning letters to three manufacturers last month, including a COVID-19 test company as well as two infusion firms under the same ownership.
You may also be interested in...
The European pharmaceutical industry federation, EFPIA, says its member companies are not looking for shortcuts to develop and validate digital biomarkers, but want help from regulators to create the right evidence.
Low- and middle-income countries need to have the know-how, capability and capacity to produce mRNA vaccines, from concept, design and testing through to manufacturing and registration, a conference heard this week.
The number of conditional marketing authorization non-renewals could increase.